TITLE

Stage IV Melanoma: Completely Resectable Patients are Scarce

AUTHOR(S)
Wevers, K.; Hoekstra, H.
PUB. DATE
July 2013
SOURCE
Annals of Surgical Oncology: An Oncology Journal for Surgeons;Jul2013, Vol. 20 Issue 7, p2352
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
88005798

 

Related Articles

  • SW06 S9430: Complete surgical resection associated with prolonged 0S in stage IV melanoma. Fisher, Stacey L.; Harris, Jason; Shafer, Emily // Hem/Onc Today;11/25/2011, Vol. 12 Issue 22, p64 

    The article presents a study that investigated the link between patients who had complete surgical resection and prolonged overall survival in stage IV melanoma.

  • Adrenalectomy for Metastatic Melanoma: Current Role in the Age of Nonsurgical Treatments. FLAHERTY, DEVIN C.; DEUTSCH, GARY B.; KIRCHOFF, DANIEL D.; LEE, JIHEY; HUYNH, KELLY T.; LEE, DAVID Y.; FOSHAG, LELAND J.; BILCHIK, ANTON J.; FARIES, MARK B.; D Kirchoff, Daniel // American Surgeon;Oct2015, Vol. 81 Issue 10, p1005 

    Surgical resection of metastases to the adrenal gland can improve overall survival of patients with stage IV melanoma, but its relative value with respect to current nonsurgical therapies is unknown. We hypothesized that surgery remains an optimal first-line treatment approach for resectable...

  • Melanoma vaccine trial recruits wanted. Cameron, Amanda // New Zealand Doctor;7/12/2006, p10 

    The article reports that patients with melanoma in New Zealand are being sought to participate in an international trial investigating a new vaccine. The participants, who must have stage IIC, IIIb, IIIc or IV melanoma, will be given an immune stimulant called ISCOMATRIX or both ISCOMATRIX or...

  • Peptide vaccination induces specific effector and memory T cells but fails to enhance preexisting T cell immunity. Letsch, A.; Keilholz, U.; Nagorsen, D.; Asemissen, A. M.; Thiel, E.; Scheibenbogen, C. // Cancer Cell International;2004 Supplement 1, Vol. 4, pS48 

    The article evaluates the immunogenicity of tyrosinase peptides in the combination with the adjuvants GM-CSF and KLH in patients with relapsed resected stage III/ IV melanoma. It indicates that a preexisting T cell response to a peptide significantly impairs the ability of the vaccine to expand...

  • Dabrafenib/vemurafenib.  // Reactions Weekly;Apr2014, Vol. 1496 Issue 1, p14 

    The article presents case studies of two elderly patients who developed cutaneous granulomatous eruptions while receiving treatment with dabrafenib or vemurafenib for metastatic melanoma. One case is of a woman in her 80s who was diagnosed with M1a stage IV metastatic melanoma. The second case...

  • Vemurafenib.  // Reactions Weekly;1/12/2013, Issue 1434, p64 

    The article describes the cases of three patients with stage IV melanoma who developed vasculitis or panniculitis after initiating vemurafenib.

  • Vemurafenib.  // Reactions Weekly;Aug2015, Vol. 1562 Issue 1, p208 

    The article describes cases of panniculitis in three female patients while receiving vemurafenib for stage IV melanoma, with one of the patient also developing arthralgia.

  • Doxorubicin/ifosfamide.  // Reactions Weekly;Mar2015, Vol. 1542 Issue 1, p96 

    An abstract of the article "Treatment outcomes in completely resected stage i to stage iv uterine carcinosarcoma with rhabdomyosarcoma differentiation," by V. Makker and colleagues is presented.

  • Successful Treatment of Metastatic Malignant Melanoma with Viscum album Extract (Iscador® M). Kirsch, Angelika // Journal of Alternative & Complementary Medicine;May2007, Vol. 13 Issue 4, p443 

    Background: Recent study results demonstrate possible clinical benefit from adjuvant treatment with a standardized mistletoe ( Viscum album) extract in patients with malignant melanoma. Patient and method: We present a male patient, currently 68 years of age, with one malignant melanoma at the...

  • Stage IV hepatocellular carcinoma with portal venous tumor thrombus: complete response after combined therapy of repeated arterial chemoembolization and radiofrequency ablation. Zheng, Rong Qin; Kudo, Masatoshi; Minami, Yasunori; Inui, Kanae; Chung, Hobyung // Journal of Gastroenterology;2003, Vol. 38 Issue 4, p406 

    Reports the case of a patient with stage IV hepatocellular carcinoma (HCC) with portal venous tumor thrombus (PVTT) in whom complete response and disappearance of PVTT was achieved. Combined therapy of repeated arterial chemoembolization and radiofrequency ablation; Inadvisability of resection...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics